Scientist, CMC Analytical - Cell Biology
- Employer
- Precision BioSciences, Inc.
- Location
- Durham, NC, United States
- Start date
- Oct 26, 2020
View more
- Discipline
- Science/R&D, Biotechnology
- Required Education
- Doctorate/PHD/MD
- Position Type
- Full time
- Hotbed
- Bio NC
Job Details
Essential Duties and Responsibilities
Reasonable accommodations may be made to enable individuals with disabilities to perform the essential functions of this position. This list contains the major duties and requirements of the job and is not all-inclusive. Incumbent(s) may be expected to perform role-related duties other than those contained in this document.
- Design, develop, characterize and document analytical methods for the phenotypic characterization of genome-edited cell therapy products
- Multi-color Flow Cytometry
- Immunoassay
- Bioassay
- Lead and coordinates multiple research programs simultaneously with very limited oversight from management
- Mentor and train laboratory staff in the development and execution of cellular immunology assays
- Author, review and approve technical documents
- Work with a cross-functional team to advance genome-edited cell therapy programs
- Stay abreast of advances in the field of CAR-T cell therapy, including reviews of scientific literature and attendance at conferences
Qualifications
The requirements listed below are representative of the knowledge, skill, and/or ability required to perform this job successfully.
Required:
- Ph.D. in biological sciences with 2-5 years of postdoctoral experience, or biotechnology/pharmaceutical experience, or equivalent combination of education and experience
- Ability to conduct research projects independently and analyze results
- Strong experience in multi-parametric flow cytometry
- Direct leadership experience managing a team of direct reports
Preferred:
- Experience with cellular immunology assay development, including multiplex cytokine analysis and immunological functional assays
- Background in immunology
- Experience with mammalian cell culture
- Strong communication skills, including written and verbal reporting to supervisor, team, multiple stakeholders across the company, and at conferences.
Travel Requirements
- This position requires little to no travel.
Location
- This is an office-based position located at the main headquarters in downtown Durham, NC.
Precision BioSciences is dedicated to improving life through its proprietary genome editing platform, ARCUS. Precision BioSciences leverages ARCUS in the development of its product candidates which are designed to treat human diseases and create healthy and sustainable food and agriculture solutions. Precision BioSciences is actively developing product candidates in three innovative areas: allogeneic CAR T immunotherapy, in vivo gene correction, and food.
Precision BioSciences provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, gender identity or expression, national origin, age, disability, genetic information, marital status, amnesty, or status as a covered veteran in accordance with applicable federal, state and local laws. Precision BioSciences complies with applicable state and local laws governing non-discrimination in employment in every location in which the company has facilities. This policy applies to all terms and conditions of employment, including, but not limited to, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation, and training.
Company
Precision BioSciences, Inc. (Nasdaq: DTIL) is a clinical stage gene editing company developing in vivo gene editing and ex vivo allogeneic CAR T therapies with its highly precise and versatile ARCUS genome editing platform. ARCUS uses sequence-specific DNA-cutting enzymes, or nucleases designed for gene knock out, as well as highly sophisticated edits for gene insertion and/or gene repair. Precision’s in vivo gene editing pipeline consists of wholly-owned preclinical candidates for primary hyperoxaluria type 1 (PBGENE-PH1), familial hypercholesteremia (PBGENE-PCSK9) and chronic hepatitis B (PBGENE-HBV). It has also partnered with Lilly to develop candidates for Duchenne muscular dystrophy and two other programs targeting the liver and CNS. Precision’s allogeneic CAR T pipeline consists of multiple investigational candidates in early-stage clinical trials, including its first and second generation CD19 targeting candidates PBCAR0191 and PBCAR19B for relapsed and/or refractory (R/R) non-Hodgkin and B-cell lymphoma patients. Precision has also prioritized development of PBCAR269A, its BCMA targeted candidate in combination with a gamma secretase inhibitor for R/R patients with multiple myeloma. Precision BioSciences and its in-house manufacturing facility for AAV, mRNA, and CAR T cells is based in Durham, North Carolina. For more information about Precision BioSciences please visit www.precisionbiosciences.com
Stock Symbol: DTIL
Stock Exchange: NASDAQ
- Website
- http://www.precisionbiosciences.com/
- Phone
- 919-314-5512
- Location
-
302 East Pettigrew Street
Durham
North Carolina
27701
US
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert